You are here

US FDA approves generic cholesterol-lowering pill

Nod for generic Crestor deals blow to AstraZeneca as price could drop 80-90%
Friday, July 22, 2016 - 05:50

New York

THE US Food and Drug Administration (FDA) said on Wednesday that it had approved generic versions of the blockbuster cholesterol-lowering pill Crestor, rejecting a last-ditch and controversial effort by AstraZeneca to stop cheaper competition from reaching pharmacy shelves.